Loading…
A double-edged sword: ROS related therapies in the treatment of psoriasis
In the onset and progression of psoriasis, redox imbalance is a vital factor. It's widely accepted that too much reactive oxygen species (ROS) always make psoriasis worse. Recent research, however, has shown that the accumulation of ROS is not entirely detrimental, as it helps reduce psoriasis...
Saved in:
Published in: | Asian journal of pharmceutical sciences 2022-11, Vol.17 (6), p.798-816 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In the onset and progression of psoriasis, redox imbalance is a vital factor. It's widely accepted that too much reactive oxygen species (ROS) always make psoriasis worse. Recent research, however, has shown that the accumulation of ROS is not entirely detrimental, as it helps reduce psoriasis lesions by inhibiting epidermal proliferation and keratinocyte death. As a result, ROS appears to have two opposing effects on the treatment of psoriasis. In this review, the current ROS-related therapies for psoriasis, including basic and clinical research, are presented. Additionally, the design and therapeutic benefits of various drug delivery systems and therapeutic approaches are examined, and a potential balance between anti-oxidative stress and ROS accumulation is also trying to be investigated.
ROS plays a double-edged role in the treatment of psoriasis. Reducing the level of ROS can alleviate oxidative stress, while the accumulation of ROS inhibits epidermal hyperplasia by inducing apoptosis. Both ways can improve the symptoms of psoriasis. [Display omitted] |
---|---|
ISSN: | 1818-0876 2221-285X |
DOI: | 10.1016/j.ajps.2022.10.005 |